lifestyle.californiaconsumerbanking.com

Author: Faron Pharmaceuticals

Faron Pharmaceuticals Ltd: Faron Appoints New CTO to Strengthen Late-Stage Development Activities

May 3, 2026
Faron Pharmaceuticals Ltd: Director Dealing

May 2, 2026
Faron Pharmaceuticals Ltd: Holding(s) in Company

May 1, 2026
Update to Faron’s Financial Calendar and Date of the Annual General Meeting in 2026

May 1, 2026
CORRECTION: Faron Pharmaceuticals Ltd’s Annual Report 2025 published

April 30, 2026
Faron’s Financial Statements Release 1 January to 31 December 2025

April 30, 2026
Faron Pharmaceuticals Ltd’s Annual Report 2025 Published

April 30, 2026
Faron Pharmaceuticals Ltd: Results of the Extraordinary General Meeting

April 29, 2026
Faron and City of Hope in Process of Developing a Phase II Investigator-Initiated Trial of Bexmarilimab in Relapsed/Refractory MDS

April 29, 2026
Faron’s Bexmarilimab Data Accepted for Poster Presentation at the BSH Annual Scientific Meeting 2026

April 28, 2026